Fifty-nine community-acquired pneumonias were treated in a randomized double blind trial with cefamandole or ceftazidime. A prospective scoring system was used to define severity. This made use of basic clinical data, associated diseases, white blood count, blood gases and chest radiographs. There were no serious side-effects from the drugs. There were two deaths and six failed treatment. The scoring system which defined an 'ill group' showed as good a response of these ill patients to the new cephalosporin, ceftazidime as to cefamandole.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jac/12.suppl_a.27 | DOI Listing |
Publication Analysis
Top Keywords
ceftazidime cefamandole
8
scoring system
8
cefamandole treatment
4
treatment pneumonia
4
pneumonia fifty-nine
4
fifty-nine community-acquired
4
community-acquired pneumonias
4
pneumonias treated
4
treated randomized
4
randomized double
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!